![Neuartige Chitosanpartikel und Verkapselungstechnologien sollen helfen, mRNA- und andere Wirkstoffe effizienter herzustellen. © Fraunhofer IPK / Larissa Klassen / Novel chitosan particles and encapsulation technologies shall help to produce mRNA therapeutics and other medication more efficiently. © Fraunhofer IPK / Larissa Klassen Neuartige Chitosanpartikel und Verkapselungstechnologien sollen helfen, mRNA- und andere Wirkstoffe effizienter herzustellen. © Fraunhofer IPK / Larissa Klassen / Novel chitosan particles and encapsulation technologies shall help to produce mRNA therapeutics and other medication more efficiently. © Fraunhofer IPK / Larissa Klassen](/uploads/images/_scale/pshelimolbiolab05web_169_626x352.jpg)
-
- Medicines
Efficient and stable – new technologies for producing mRNA-based pharmaceuticals
mRNA-based vaccines have been one of the key elements in the fight against the coronavirus. The technology was originally developed for cancer therapy and can be used to treat many diseases. Together with partners from science and industry, Fraunhofer IPK is now researching how mRNA therapeutics and…